Sivik Global Healthcare’s Baxter International BAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-75,000
| Closed | -$2.27M | – | 49 |
|
|
2025
Q2 | $2.27M | Sell |
75,000
-100,000
| -57% | -$3.03M | 0.62% | 41 |
|
|
2025
Q1 | $5.99M | Buy |
+175,000
| New | +$5.72M | 3.24% | 16 |
|
|
2024
Q4 | – | Sell |
-150,000
| Closed | -$5.7M | – | 40 |
|
|
2024
Q3 | $5.7M | Buy |
150,000
+50,000
| +50% | +$1.84M | 2.41% | 17 |
|
|
2024
Q2 | $3.35M | Sell |
100,000
-30,000
| -23% | -$1.11M | 1.2% | 31 |
|
|
2024
Q1 | $5.56M | Buy |
+130,000
| New | +$5.29M | 1.3% | 22 |
|
|
2023
Q4 | – | Sell |
-125,000
| Closed | -$4.72M | – | 41 |
|
|
2023
Q3 | $4.72M | Sell |
125,000
-35,000
| -22% | -$1.49M | 2.38% | 24 |
|
|
2023
Q2 | $7.29M | Buy |
160,000
+10,000
| +7% | +$435K | 1.71% | 18 |
|
|
2023
Q1 | $6.08M | Hold |
150,000
| – | – | 2.62% | 17 |
|
|
2022
Q4 | $7.65M | Buy |
150,000
+30,000
| +25% | +$1.61M | 3.6% | 9 |
|
|
2022
Q3 | $6.46M | Buy |
120,000
+55,000
| +85% | +$3.31M | 3.59% | 5 |
|
|
2022
Q2 | $4.17M | Buy |
65,000
+5,000
| +8% | +$363K | 2.37% | 20 |
|
|
2022
Q1 | $4.65M | Sell |
60,000
-15,000
| -20% | -$1.26M | 1.92% | 27 |
|
|
2021
Q4 | $6.44M | Sell |
75,000
-40,000
| -35% | -$3.22M | 2.76% | 17 |
|
|
2021
Q3 | $9.25M | Buy |
115,000
+45,000
| +64% | +$3.56M | 2.21% | 11 |
|
|
2021
Q2 | $5.63M | Sell |
70,000
-10,000
| -13% | -$839K | 1.1% | 29 |
|
|
2021
Q1 | $6.75M | Buy |
80,000
+5,000
| +7% | +$397K | 2.46% | 22 |
|
|
2020
Q4 | $6.02M | Sell |
75,000
-10,000
| -12% | -$792K | 2.45% | 23 |
|
|
2020
Q3 | $6.84M | Buy |
+85,000
| New | +$7.15M | 2.94% | 18 |
|
|
2020
Q2 | – | Sell |
-15,000
| Closed | -$3.41M | – | 52 |
|
|
2020
Q1 | $3.41M | Sell |
15,000
-55,000
| -79% | -$4.75M | 1.34% | 35 |
|
|
2019
Q4 | $5.85M | Sell |
70,000
-5,000
| -7% | -$414K | 2.17% | 23 |
|
|
2019
Q3 | $6.56M | Sell |
75,000
-10,000
| -12% | -$854K | 3.31% | 8 |
|
|
2019
Q2 | $6.96M | Sell |
85,000
-20,000
| -19% | -$1.55M | 1.68% | 8 |
|
|
2019
Q1 | $8.54M | Buy |
105,000
+45,000
| +75% | +$3.28M | 3.15% | 4 |
|
|
2018
Q4 | $3.95M | Sell |
60,000
-20,000
| -25% | -$1.34M | 2.13% | 22 |
|
|
2018
Q3 | $6.17M | Hold |
80,000
| – | – | 2.2% | 20 |
|
|
2018
Q2 | $5.91M | Sell |
80,000
-20,000
| -20% | -$1.41M | 2.27% | 18 |
|
|
2018
Q1 | $6.5M | Hold |
100,000
| – | – | 3.03% | 8 |
|
|
2017
Q4 | $6.46M | Sell |
100,000
-20,000
| -17% | -$1.28M | 2.4% | 11 |
|
|
2017
Q3 | $7.53M | Buy |
120,000
+20,000
| +20% | +$1.24M | 2.56% | 12 |
|
|
2017
Q2 | $6.05M | Sell |
100,000
-10,000
| -9% | -$568K | 2.22% | 16 |
|
|
2017
Q1 | $5.71M | Buy |
+110,000
| New | +$5.41M | 2.66% | 11 |
|
Other funds holding BAX
Sivik Global Healthcare's BAX Position: Q3 2025 in Review
Sivik Global Healthcare sold out of Baxter International (BAX) in Q3 2025, closing a stake of 75,000 shares — an estimated $2.27M sold.
Sivik Global Healthcare first reported a position in BAX in Q1 2017 and held it in 31 quarters. The position peaked at $9.25M in Q3 2021. 729 funds tracked by Wall St. Rank hold BAX as of Q3 2025.
- Sivik Global Healthcare reported no remaining Baxter International position as of Q3 2025 after selling out during the quarter.
- Sivik Global Healthcare sold 75,000 Baxter International shares in Q3 2025, an estimated $2.27M.
- Sivik Global Healthcare first reported a position in Baxter International in Q1 2017 and held it in 31 quarters.
- Sivik Global Healthcare's Baxter International position peaked at $9.25M in Q3 2021.
- 729 funds tracked by Wall St. Rank held Baxter International as of Q3 2025.
Based on Sivik Global Healthcare's 13F filing for Q3 2025, filed 23 Oct 2025.